![Michael Mano](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 194 460 $ in data 31/08/2026
Michael Mano is Secretary, Chief Legal Officer & Executive VP at Karyopharm Therapeutics, Inc. since 2020.
Mr. Mano is Trustee at XenoTherapeutics, Inc. Formerly, Mr. Mano was Counsel-Business Development at Biogen, Inc. from 2018 to 2020.
Mr. Mano was Senior Counsel at Proskauer Rose LLP from 2013 to 2018.
Education includes undergraduate studies at St. Michael's College and graduate studies at Washington University School of Law.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 14/05/2026 | 94.398 ( 0,42% ) | 194 460 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Consigliere Generale | 15/12/2020 |
XenoTherapeutics, Inc.
 XenoTherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/12/2020 |
Proskauer Rose LLP
 Proskauer Rose LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01/01/2018 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Proskauer Rose LLP
Proskauer Rose LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
St. Michael's College
 St. Michael's College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
Washington University School of Law
 Washington University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
XenoTherapeutics, Inc.
XenoTherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
